Immunotherapy
911 articles
Meet the Researcher: Jeffrey Patterson-Fortin, M.D., Ph.D.
Researcher Dr. Jeffrey Patterson-Fortin focuses on DNA damage repair as he looks for better pancreatic cancer treatments.
Study Shows Fungi Boost Pancreatic Cancer Development and Growth
Drs. George Miller and Berk Aykut are leading research into the role of fungi in the growth and development of pancreatic cancer.
What Drives Pancreatic Cancer Spread?
Dr. Gina Razidlo and her team focus on how stop metastasis–pancreatic cancer spreading–to aid in drug development.
New Study Tackles the Link Between Sleep Disruption and Cachexia
Cachexia occurs frequently among pancreatic cancer patients. Dr. Evan Noch is looking at how sleep disruption and cachexia interact.
Diversity Lacking in Pancreatic Cancer Trials
Drs. Kelly Herremans and Jose Trevino report on the lack of diversity in pancreatic cancer clinical trials, and possible root causes.
Tweeting About Tumors and How Best to Provide Care
Dr. Michael Pishvaian launches #TumorBoardTuesday, a continuing medical education Twitter chat, to discuss patient treatments for GI cancers.
Tumor Subtypes Potentially Provide Clues About Prognosis and Treatment
Drs. Andrew Aguirre and David Ting are teasing out the differences between pancreatic cancer subtypes, to get treatments that work better.
What Happens When Pancreatic Cancer Clinical Trials Fail?
Why do clinical trials fail? What about the patients on the trial? Learn more about what happens when pancreatic cancer clinical trials fail.
The Link Between Depression and Pancreatic Cancer
Drs. Annette Stanton and Michael Irwin outline the links between depression and pancreatic cancer, both as a symptom of the disease and post-diagnosis.
Targeting Cancer Metabolism
Researchers from Tyme Technologies are focusing on cancer cell metabolism, particularly tyrosine, as a way to kill cancer cells.
New Gene Inhibitor Drug for Patients with MTAP-Deleted Tumors
A new trial targets patients with advanced solid tumors, including pancreatic cancer, with an MTAP-deletion genetic mutation.
Five Promising Researchers Leading the Charge in Treatment Advancements
Meet the five promising researchers supported by Let’s Win at the 2023 AACR Special Conference on Research: Pancreatic Cancer.
Adjuvant Chemotherapy with Modified FOLFIRINOX Regimen Improves Survival
A French clinical trial showed that adjuvant chemotherapy (given after surgery) with modified FOLFIRINOX improves survival of pancreatic cancer patients.
Adding Focused Radiation to Standard Pancreatic Cancer Treatment
Researchers are using IORT–intraoperative radiation therapy–to treat pancreatic cancer that cannot be surgically removed.
Cherishing the Simple Things
Elizabeth O’Connor has a PALB2 genetic mutation so her stage IV pancreatic cancer has responded to immunotherapy.